Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8713267 | Journal of Allergy and Clinical Immunology | 2018 | 42 Pages |
Abstract
In summary, CNTO3157 was ineffective in attenuating the effect of HRV-16 challenge on lung function, asthma control, and symptoms in asthmatic patients but suppressed cold symptoms in healthy subjects. Other approaches, including blockade of multiple pathways or antiviral agents, need to be sought for this high unmet medical need.
Keywords
CCSSmodified intention to treatRIG-IHSV-1PEFRFeNOPoly-I:Cretinoic acid–inducible gene ICSAsTLRICSAUCHRVmITTAsthmainflammationToll-like receptorFraction of exhaled nitric oxidepeak expiratory flow rateHuman rhinovirusadverse eventViral infectionPharmacodynamicsPharmacokineticsarea under the curveHerpes simplex virus 1Polyinosinic:polycytidylic acidInhaled corticosteroidToll-like receptor 3
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Philip E. MD, Susan PhD, Robert MS, Mathew J. PhD, Peter J. MD, Rene MD, Zuzana MD, Ronald B. MD, Brian J. MD, David PhD, Dave MD, Andreas MD, Vibeke MD, James E. MD, Christian MD, Scott A. MD, Tjeert T. MD, Alfred M. PhD, Sebastian L. MD,